Cargando…
维奈克拉联合阿扎胞苷治疗不适合标准化疗的新诊断急性髓系白血病疗效分析：单中心数据
OBJECTIVE: To investigate the effectiveness and safety of the VA regimen, which combines venetoclax with azacitidine in the treatment of patients with newly diagnosed acute myeloid leukemia（AML）who are not suitable candidates for conventional chemotherapy. METHODS: In the Department of Hematology at...
| Formato: | Online Artículo Texto |
|---|---|
| Lenguaje: | English |
| Publicado: |
Editorial office of Chinese Journal of Hematology
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669628/ https://www.ncbi.nlm.nih.gov/pubmed/36709196 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2022.10.005 |